ASP
  • COVID
    • INPATIENT >
      • CONSIDERATIONS & LABS
      • PAXLOVID
      • REMDESIVIR
      • OLUMIANT
      • ACTEMRA
      • STEROIDS
      • VTE
    • OUTPATIENT
  • Education
    • Bugs & Tips
    • Agents & Spectra
  • Guidelines
    • By Infection Type
    • Surgical Prophylaxis >
      • By Procedure
      • Dosing Guide
  • Formulary
  • Antibiogram
    • 2023 Inpatient
    • 2023 Outpatient
    • 2022 Inpatient
    • 2022 Outpatient
    • 2021 Inpatient
    • 2021 Outpatient
    • 2020 Inpatient
    • 2019 Inpatient
    • 2019 Outpatient
  • About
    • ASP Program
    • Stats & Data >
      • Recommendations
      • Pharmacy Data
      • MDR ORGANISMS
      • DDD/DOT
    • Contact

Impetigo & Ecthyma

CAUSATIVE ORGANISMS
  • Staph. aureus and/or b-hemolytic Streptococcus

RECOMMENDED TREATMENT
  • Gram stain and culture pus or exudates recommended
  • Bullous or nonbollous
    • ​TREAT WITH ORAL OR TOPICAL ANTIBIOTICS
    • Oral therapy recommended for patients with numerous lesions or outbreaks affecting multiple people
    • Ecthyma treatment: always use oral antibiotics to treat
​
TOPICAL ANTIBIOTICS
  • Topical Retapamulin ointment BID x 5 days
  • Topical mupirocin ointment BID x 5 days or​

ORAL ANTIBIOTICS
  • Cephalexin 500 mg PO QID x 7 days
  • Amoxicillin/clavulanate 875/125 mg PO q12h x 7 days
  • Clindamycin 300mg PO QID x 7 days
  • Dicloxacillin 500 mg PO QID x 7 days
  • If MRSA suspected/confirmed, use one of the following instead:
    • Sulfamethoxazole/Trimethoprim 800/160 mg 1-2 tablets PO BID x 7 days
    • Doxycycline 100 mg PO BID x 7 days
    • Clindamycin 300 mg PO QID x 7 days
    • Linezolid 600 mg PO BID x 7 days (last line as some insurance companies will not cover it)
  • COVID
    • INPATIENT >
      • CONSIDERATIONS & LABS
      • PAXLOVID
      • REMDESIVIR
      • OLUMIANT
      • ACTEMRA
      • STEROIDS
      • VTE
    • OUTPATIENT
  • Education
    • Bugs & Tips
    • Agents & Spectra
  • Guidelines
    • By Infection Type
    • Surgical Prophylaxis >
      • By Procedure
      • Dosing Guide
  • Formulary
  • Antibiogram
    • 2023 Inpatient
    • 2023 Outpatient
    • 2022 Inpatient
    • 2022 Outpatient
    • 2021 Inpatient
    • 2021 Outpatient
    • 2020 Inpatient
    • 2019 Inpatient
    • 2019 Outpatient
  • About
    • ASP Program
    • Stats & Data >
      • Recommendations
      • Pharmacy Data
      • MDR ORGANISMS
      • DDD/DOT
    • Contact